Progress in the treatment of Parkinson's disease.
D002395:Catecholamines / Q000009:adverse effects; D004295:Dihydroxyphenylalanine / Q000378:metabolism / Q000627:therapeutic use*; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*
D002395:Catecholamines; D004295:Dihydroxyphenylalanine